| Betatrophin correlations | All study participants (n = 45) | Nondiabetic (n = 18) | Type 2 diabetes (n = 27) |
| Age (years) | Ns, cc = 0.113 |
*
P = 0.01 cc = 0.572 | Ns, cc = 0.075 | Weight (kg) | Ns, cc = 0.0535 | Ns, cc = −0.236 | Ns, cc = 0.176 | BMI (kg/m2) | Ns, cc = 0.0915 | Ns, cc = −0.164 | Ns, cc = 0.15 | Waist (cm) | Ns, cc = 0.111 | Ns, cc = −0.173 | Ns, cc = 0.192 | Hip (cm) | Ns, cc = −0.0740 | Ns, cc = −0.142 | Ns, cc = 0.411 | Waist-hip ratio | NS, cc = −0.243 | Ns, cc = −0.143 | Ns, cc = −0.415 | Fasting plasma glucose (mmol/L) | Ns, cc = 0.235 | Ns, cc = −0.054 | Ns, cc = 0.082 | HbA1c (% (mmol/mol)) |
*
P = 0.0005 cc = 0.495 | Ns, cc = −0.060 |
*
P = 0.01 cc = 0.482 | HOMA2%B | Ns, cc = −0.0502 | Ns, cc = 0.28 | Ns, cc = 0.0389 | HOMA2%S | Ns, cc = 0.0685 | Ns, cc = −0.13 | Ns, cc = 0.119 | HOMA2 IR | Ns, cc = 0.190 | Ns, cc = 0.18 | Ns, cc = 0.109 | Fasting plasma cholesterol (mmol/L) | Ns, cc = −0.286 | Ns, cc = −0.21 | Ns, cc = −0.06 | Fasting plasma HDL cholesterol mmol/L | Ns, cc = −0.0835 | Ns, cc = 0.18 | Ns, cc = −0.022 | Fasting plasma LDL cholesterol mmol/L | Ns, cc = −0.230 | Ns, cc = −0.33 | Ns, cc = 0.087 | Fasting plasma triacylglycerols (mmol/L) | Ns, cc = −0.178 | Ns, cc = −0.27 | Ns, cc = −0.12 | Plasma creatinine (µmol/L) | Ns (P = 0.0579), cc = 0.267 | Ns, cc = −0.045 | Ns, cc = 0.342 | GFR-MDRD (mL/min) | Ns (P = 0.17), cc = −0.208 | Ns, cc = −0.169 | Ns, cc = −0.209 | Fasting plasma C-peptide (nmol/L) | Ns, cc = 0.168 | Ns, cc = 0.195 | Ns, cc = 0.103 |
|
|